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Abstract
Objective—Repetitive behaviors in autism spectrum disorders (ASD) range from motor
stereotypy to immersion in restricted interests. The modified Children's Yale–Brown Obsessive
Compulsive Scale for children with autism spectrum disorder (CYBOCS-ASD) includes a
Symptom Checklist (behavior present or absent) and five severity scales (Time Spent,
Interference, Distress, Resistance and Control).
Method—We assembled CYBOCS-ASD data from 3 Research Units on Pediatric
Psychopharmacology Autism Network trials to explore the component structure of repetitive
behaviors in children with ASD. Raters trained to reliability conducted the CYBOCS-ASD in 272
medication-free subjects. Fifteen Checklist items were endorsed for less than 5% of the sample
and were dropped. Principal Component Analysis (PCA) was used to explore the clustering of 23
checklist items. Component scores computed for each subject were correlated with other
measures. We also examined the distribution of severity scales.
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Results—The subjects (229 boys, 43 girls; mean age = 7.8±2.6 years) met criteria for an ASD;
half were intellectually disabled. The PCA resulted in a 5-component solution to classify repetitive
behaviors (34.4% of the variance): Hoarding and Ritualistic Behavior; Sensory and Arranging
Behavior; Sameness and Self-injurious Behavior; Stereotypy; Restricted Interests. Sensory and
Arranging and Stereotypy components were associated with lower adaptive functioning (Pearson r
ranged from .2 to .3; p < 0.003). The Resistance scale showed little variation with over 60% of
sample with the highest score.
Conclusions—Rarely endorsed checklist items can be dropped. The Resistance item does not
appear relevant for children with ASD.
Keywords
autism spectrum disorder; clinical trials; outcome measures; repetitive behavior
INTRODUCTION
Autism spectrum disorder (ASD) is a chronic condition of early childhood onset defined by
impaired social interaction and social communication as well as repetitive behavior and
restricted interests.1 Current prevalence estimates for ASD range from 0.6 to 1.3% of
school-age children in the US.2,3 Two medications (risperidone and aripiprazole) are
currently approved by the US Food and Drug Administration for treating irritability
(tantrums, aggression, and self-injury) in children with more narrowly defined autistic
disorder. Empirically supported treatments for impaired social interaction or repetitive
behavior are less well established and hampered by incomplete consensus on outcome
measurement.
Repetitive behavior is a defining feature of other psychiatric disorders including Tourette
syndrome (TS) and, obsessive-compulsive disorder (OCD). Tics in TS range from eye
blinking, head jerking, and throat clearing to more complex touching habits and blurting out
words or parts of words.4 In OCD, children may show hand-washing, checking or elaborate
rituals to prevent harm, or touching in patterns to achieve a sense of completion. 5,6
Children with ASD may exhibit stereotypic motor behavior such as hand flapping, rocking,
spinning objects, or more complex behaviors such as repeatedly watching particular video
segments.7,8 Several investigators have described ‘higher’ and ‘lower’ order repetitive
behaviors.9-12 In this model, higher order behaviors reflect insistence on routines and more
purposeful behavior (watching the same video); lower order behaviors include motor
stereotypies or sensory-motor behavior such as spinning an object. Other investigators
propose circumscribed interests as a third domain.11 The behavioral correlates of
circumscribed interests might include reading books on certain subject or talking about that
topic (e.g., mechanical devices) to the exclusion of other topics.13 In contrast to the
unwanted repetitive behaviors in TS and OCD, children with ASD may not struggle against
their repetitive behaviors. Indeed, for many children with ASD the repetitive behavior is a
preferred activity. For some children, frustration, protest and tantrums may occur when the
child is asked to stop the behavior.7,13
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In preparation for multisite trials in ASD, the Research Units on Pediatric
Psychopharmacology (RUPP) Autism Network modified the Children's Yale–Brown
Obsessive Compulsive Scale (CYBOCS).7 The original CYBOCS is a clinician-rated
interview designed to measure current symptom severity in youth with OCD.14 It contains
separate checklists for obsessions and compulsions, 5 severity items for obsessions and five
for compulsions. The severity items are scored from 0 (not present) to 4 (extreme), yielding
an Obsessions score of 0 to 20, a Compulsions score of 0 to 20, and a total of 0 to 40. Given
the challenge of ascertaining obsessions in individuals with ASD, the modified CYBOCS
for ASD retains only the five compulsion items.7 We also added items to the compulsions
checklist and made minor adjustments to the severity anchor points for use in children with
ASD. The revised instrument has demonstrated reliability and validity and has also
demonstrated sensitivity to change.7,15 The purpose of this study is to extend our previous
work on adapting the original CYBOCS as an outcome measure in pediatric clinical trials in
ASD. To this end, we examined the component structure of the compulsions checklist and
the distribution of severity scores on the CYBOCSASD in a sample of well-characterized
children with ASD.
METHOD
Participants and Setting
Two hundred ninety one (291) subjects participated in 1 of 3 multisite, randomized trials
conducted by the RUPP Autism Network. 16-19 Baseline CYBOCS-ASD checklists were
missing or illegible for 19 subjects. Thus, the study sample included 272 subjects (229 boys,
43 girls; aged 4–17 years). The institutional review board at each site approved the studies
and written informed consent was obtained from parents or legal guardians prior to data
collection. Assent was obtained from children who were able to understand the details of
their involvement.
Eligible subjects at baseline were healthy, had a mental age of 18 months or higher, were
free of a psychiatric condition requiring another treatment and were medication-free for at
least 2 weeks (one month for fluoxetine or antipsychotic medications). In the first trial
(RUPP I), 101 subjects with autistic disorder (age 5 to 17 years) accompanied by serious
behavioral problems (Aberrant Behavior Checklist [ABC] Irritability subscale ≥ 18) were
randomly assigned risperidone or placebo for eight weeks (RUPP Autism Network, 2002).
RUPP II compared three doses of methylphenidate to placebo in 66 children (age 5 to 14
years) with autistic disorder, Asperger's disorder or pervasive developmental disorder not
otherwise specified (PDD-NOS) plus hyperactivity in a 4-week crossover trial (RUPP
Autism Network, 2005). 17 In the third trial (RUPP III), 124 children (age 4.5 to 13 years)
with ASD and serious behavioral problems (ABC Irritability subscale ≥ 18) were randomly
assigned to risperidone only or risperidone plus parent training for 6 months.18,19
Procedures
The clinical assessments were conducted by experienced multidisciplinary teams and
included complete medical, developmental, and psychiatric histories, tests of IQ and
adaptive functioning, as well as parent interviews and questionnaires.16-19 The ASD
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diagnosis was based on clinical interview, observation and supported by Autism Diagnostic
Interview–Revised (Lord et al., 1997).20
Measures
Intellectual Functioning—We used one of several standard tests according to the child's
ability: Wechsler Intelligence Scale for Children -III; Leiter International Performance
Scale–Revised; Mullen Scales of Early Learning; Slosson Intelligence Test; or Stanford-
Binet, version 5. Given the use of multiple tests, we classified subjects as intellectually
disabled (IQ < 70) or in the normal range (IQ ≥ 70).
Vineland Adaptive Behavior Scales, Survey Edition (Vineland; Sparrow, Balla,
and Cicchetti, 1984)—The Vineland is an age and gender standardized measure of
adaptive functioning (population mean of 100 ± 15) across three domains: Communication,
Socialization, and Daily Living Skills. Vineland items are scored 0 (behavior not
performed), 1 (performed sometimes) or 2 (performed on a regular basis).21
Aberrant Behavior Checklist (ABC).22—This reliable and valid, 58-item informant-
based scale (scored 0 to 3) contains 5 factor-analyzed subscales: Irritability, Social
Withdrawal, Stereotypy, Hyperactivity, and Inappropriate Speech.
Clinical Global Impression Scale-Severity (CGI-S)23—The CGI-S is a commonly
used, clinician-rated scale assessing overall impairment. Raters were trained to reliability on
this 7-point scale that ranges from non-symptomatic (1) to extreme (7). In these 3 trials; a
score of 4 (Moderate) or greater was required for entry.
Child and Adolescent Symptom Inventory (CASI).24—This 132-item, DSM-IV–
referenced, parent-rated scale was used to screen for psychiatric disorders. Items are scored
from 0 (never) to 3 (very often) and can be scored dimensionally as the sum of the scores for
the specific diagnostic subscale (e.g., attention-deficit/hyperactivity disorder [ADHD],
depression, etc.). The CASI-Anxiety scale is a reliable, 20-item subscale that contains items
of generalized anxiety, separation anxiety, social phobia, panic and specific phobia.265The
CASI-PDD scale includes 12 items on social deficits, communication problems, and
repetitive behaviors.
Children's Yale–Brown Obsessive Compulsive Scale modified for Autism
Spectrum Disorder (CYBOCS-ASD).7—The 5-item CYBOCS-ASD is a clinician-rated
measure designed to document the current severity of repetitive behavior in children with
ASD. The semistructured interview uses the parent as the primary informant, but children
are encouraged to participate to the extent possible.7 The interview includes a Symptom
Checklist of possible repetitive behaviors grouped in 8 categories (e.g., Washing Rituals,
Checking Behaviors, Hoarding). Raters were trained to mark current symptoms (past week)
on the checklist. The absence of a mark indicated that the behavior was not present. Each
category also permitted the interviewer to write-in “other” behaviors presumed relevant to
that overall category. For example, in the section on Repeating Rituals a query about
spinning objects might prompt the parent to report “he flips a pencil in front of his eyes.”
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Once current repetitive behaviors are identified, the interviewer inquires about Time Spent,
Interference in everyday life, Distress (if prevented from performing the behavior),
Resistance (child's own effort to limit the behaviors) and degree of Control over the
behavior—when instructed by parents to stop the behavior. Each severity item is anchored
to the past week and scored from 0 (not present) to 4 (severe) for a total score of 0 to 20.
Rater training included instruction on how to ascertain and document checklist items,
identify current target symptoms, and establish current severity. Two to three video
recordings were used to illustrate interview methods and scoring. Raters were then asked to
score 3 videos independently. Reliable raters had to be within 15% of the gold standard rater
on the total score.
Classification of Added Items
All handwritten items added to the checklist for each child were entered verbatim and
reviewed by a 2-person panel (A.D., L.S.). Similar items were collapsed to reduce item
count and avoid duplication. The resulting item list included 39 items (Table 2). Most items
were from the original checklist, some were combinations of original items (e.g., excessive
or ritualized hand washing was merged with excessive or ritualized showering, bathing,
teeth-brushing, grooming), and others were based on the handwritten items (e.g., watching
the same video segment over and over).
Analytic Plan
First, we examined the clinical characteristics of the available sample from the RUPP
Autism Network trials and the frequency of symptom endorsement on the CYBOCS
checklist. Endorsement was calculated as the number of subjects with that symptom over the
total number of subjects.
Principal components analysis (PCA) was used to examine the dimensionality of CYBOCS
checklist items. Given that the original CYBOCS checklist was developed for OCD, the
PCA proceeded without assumptions about the latent structure of the binary (present or
absent) checklist items in children with ASD. To decrease the likelihood of extracting
spurious components, we dropped items endorsed by less than 5% of the sample. 26 The
number of components extracted was determined to avoid retaining too few (under-
extraction) or too many (overextraction) components and to verify sample adequacy.27,28
Rather than relying on any single criterion (e.g., eigenvalues > 1) for determining the
number of components to extract, we considered multiple criteria: the cumulative proportion
of item covariance extracted (and the related Scree plot); whether the retained components
were well-saturated; and whether the components were well-identified.28 An orthogonal
(varimax) rotation was applied initially and the reliability of the structure was verified using
alternate orthogonal (equamax) and oblique (promax) rotations. Rotated item loadings of ≥
0.3 (moderate effect) were considered salient for interpreting the components, which were
subsequently confirmed by content experts (L.S., A.D.). Scores on components were
computed for each participant on the basis of all items loadings.
In the third set of analysis, we examined the construct validity of the identified components.
These analyses evaluated the association between component scores and scores on
Scahill et al. Page 5
J Am Acad Child Adolesc Psychiatry. Author manuscript; available in PMC 2015 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
CYBOCS severity scales (Time Spent, Interference, Distress, Resistance, and Control) using
Spearman correlation. We also examined the association of component scores with selected
subscales on the CASI, ABC subscales and Vineland scores with Pearson correlation.
Discriminant function analyses were conducted to determine whether identified components
could differentiate participants based on trial-specific treatment targets (hyperactivity in the
methylphenidate trial or serious behavioral problems in the risperidone trials), intelligence
(IQ ≥ 70 or IQ < 70), or verbal ability (verbal or nonverbal item on the Autism Diagnostic
Interview–Revised).
The final set of analysis examined the distributions of the CYBOCS-ASD dimensions (Time
Spent, Interference, Distress, Resistance, and Control) and computed the internal
consistency (Cronbach's alpha) for all 5 dimensions and with each dimension removed.
Pearson correlations were calculated for total CYBOCS-ASD scores with ABC subscales,
selected CASI subscales and Vineland score to estimate divergent validity.
RESULTS
Table 1 summarizes the clinical characteristics of the sample. Nineteen subjects were unable
to cooperate with testing and did not have an IQ score. Of those with IQ data, 141 (51.8%)
were classified as intellectually disabled (IQ < 70). Based on parent-report, the sample was
72.4% Caucasian, 12.5% African-American, 7.4% Hispanic, 5.1% Asian, and 2.6%
identified as ‘other.’
Fifteen checklist items were endorsed for less than 5% of subjects and were dropped. As
shown in Table 2, the rate of endorsement for the remaining 24 items ranged in frequency
from 7% (ordering, putting objects into proper place) to 62% (body stereotypy).
Principal Components Analysis
Twenty-four items were initially included in the PCA, however 1 item (excessive ritualized
hand washing, showering) did not reach our threshold (≥.30) on any component and was
dropped. Twenty-three checklist items were included in a second PCA (16 original items
and 7 new items). The median endorsement rate for these 23 items was 18%. This frequency
is 11 points above the minimum and 20% of the 55-point range (7 to 62%) suggesting that
pairwise disparities in marginal frequencies were not extreme and mitigates concerns
regarding binary item data. A 5-component solution provided the best classification of
repetitive behaviors (accounting for 34.4% of the variance). Four and six component
solutions were considered. The four component solution accounted for less variance; the 6-
component solution resulted in a higher number items loading on more than 1 component.
Table 3 displays the varimax rotated component structure, which was consistent across the
alternative equamax and promax rotations. The 5-component model yielded a different
structure than the original CYBOCS categories. Component I included Hoarding and
Ritualistic Behavior (e.g., counting, ritualized eating, and checking); Component II involved
Sensory/Motor (e.g., echolalia, repetitive water play) and Arranging Behaviors (e.g.,
ordering or lining up objects); Component III included Insistence on Sameness and Self-
Injurious Behaviors (SIB); Component IV comprised Stereotypy; and Component V
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captured Restricted Interests. Object Stereotypy (e.g., repetitive manipulation of a pencil,
straw, piece of string) loaded on Components III (Sameness) and IV (Stereotypy). Given the
minimal difference on loadings of object stereotypy for Components III and IV, we placed
this item on both components. A few other items showed similar loadings on more than 1
Component (Repetitive Sexual Behavior loaded on Component II (Sensory and Arranging)
and Component III (Sameness and SIB). Hair-pulling loaded on Components I and V.
Components I and III, blinking and staring rituals also loaded on Components I and IV. By
contrast, there was a higher loading for hoarding on Component I compared to Component
V (Restricted Interests), suggesting that hoarding belongs in Component I. Perhaps
fascination with a specific object (Component V) drives the reluctance to discard the object
—rather than hoarding as a general problem.
Association of the 5 Components to Other Measures
Based on parent report, many subjects exhibited repetitive behavior in more than one
component. Standardized scores (mean = 0, SD = 1) on each of the 5 components were
computed for each participant. A higher component score for a given subject reflects greater
likelihood of exhibiting that type of repetitive behavior. Table 4 presents correlations
between component scores and age as well as scores on several clinical measures.
Subjects ranked with higher scores on the CYBOCS-ASD Distress dimension were higher
on Component I (Ritualized behavior) (Spearman rho = .31, p < 0.003) (see Table 4). Scores
on the CASI Anxiety scale were associated with scores on Component I (Pearson r = .30, p
< 0.003). Subjects with higher scores on Component II scored higher on the CASI-PDD
scale (r = .33, p < 0.003). Although significant, these small to medium correlations suggest
that components are not strongly associated with clinical measures.
Discriminant function analyses demonstrated that the five component scores did not
discriminate on trial-specific targets (hyperactivity in the methylphenidate trial or serious
behavioral problems in risperidone trials; Lambda=0.964, p=0.081). However, component
scores differentiated significantly by IQ (Lambda=0.826, p<0.001). Participants with lower
IQ had lower scores on Component 1 (Hoarding and Ritualistic Behavior) (p=0.005) and
higher scores on Component II (Sensory and Rule Based Behavior) and Component IV
(Stereotypy) (p<0.001 for both). Similarly, these three component scores differentiated
among nonverbal versus verbal subjects (based on the Autism Diagnostic Interview–Revised
[ADI-R]) (Lambda=0.854, p<0.001). Participants who were nonverbal had lower scores on
Component I (p=0.005) and higher scores on Component II (p=0.021) and Component IV
(p<0.001). Component III (Sameness and SIB) and Component V (Restricted Interest) were
not significant in any discriminant analyses.
Distribution of Scores on CYBOCS-ASD Dimensions
The Resistance and Control dimensions each had a modal score of 4 compared to a modal
score of 3 for the other 3 dimensions (Table 5). The distribution of the Resistance item is
particularly distorted with over 60% of subjects rated extreme (score of 4).
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The internal consistency for the 5-item CYBOCS-ASD Total score was .81. When each item
was removed, Cronbach's alpha ranged from .76 to .79 (see Table S1, available online). The
CYBOCS-ASD total score showed modest correlations with measures of adaptive
functioning and maladaptive behavior. For example, correlations with the ABC subscales for
Irritability, Social Withdrawal, Stereotypy, and Hyperactivity ranged from .25 to .32 (p < .
01). Similarly, correlations between the CYBOCS-ASD total score and the Vineland (higher
scores reflect higher functioning) were also modest, (−.26 to −.30, p < .01 for all three
domains) (see Table S2, available online). These small to medium correlations suggest that
the CYBOCS-ASD is measuring a separate construct from these other instruments.
DISCUSSION
In its current form, the CYBOCS-ASD is a reliable and valid measure of repetitive behavior
in youth with ASD.7 The results of the current study show that several original CYBOCS
checklist items are not relevant for children with ASD and can be dropped. Twenty-three
checklist items endorsed by at least 5% of this sample fell into five components. These five
clinically plausible components explained nearly 35% of the variance. For example,
Component IV (Stereotypy) includes motor behaviors such as repetitive object
manipulation, hand and finger stereotypy, blinking and staring rituals, and repetition of
routine activities. In this sample, subjects often exhibited behaviors in more than one
component suggesting that typologies of repetitive behavior in ASD may not be strictly
drawn. By contrast, however, the discriminant function analysis showed that children with
verbal capacity (as reported on the ADI-R) and those with IQ ≥ 70 were more likely to
exhibit counting, checking, and ritualized eating behaviors (Component I) than nonverbal
children or those with intellectual disability. Lower functioning children were more likely to
engage in ordering and arranging, hand and finger stereotypy, and object manipulation
(Components II and IV). Collectively, these findings support the format of the CYBOCS-
ASD, which yields a total score based on the impact of the symptoms present rather than
subscale scores for types of repetitive behavior. A reliable and valid clinician-rated measure
with a single total score has obvious statistical advantages as an endpoint in clinical trials.
The components identified in this analysis show differences and similarities to previous
investigations. The International Classification of Disease–Tenth edition (ICD-10) describes
4 categories of repetitive behavior in ASD: (a) preoccupations with part-objects; (b)
stereotyped motor mannerisms; (c) circumscribed patterns of interest; (d) adherence to
specific routines or rituals.29 Several prior factor analyses based on the 10–12 repetitive
behavior items from the ADI-R reported 2 factors: stereotypy and insistence on sameness.30
This is consistent with the traditional concepts of ‘lower’ and ‘higher’ order behaviors.9
However, circumscribed interests were not included in most of these ADI-R factor analysis.
One study that did include circumscribed interest showed that it emerged as a third factor,
which is consistent with ICD-10.11 The limited number of repetitive behaviors on the ADI-R
may have hindered the identification more than 2 factors.
Honey et al.12 examined the factor structure of the 26-item, parent-rated Repetitive Behavior
Questionnaire (RBQ)9 in 180 children with ASD age 3 to 16 years. Children with self-
injurious behavior (SIB) were excluded from the analysis. Two factors emerged: Sensory/
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Motor behaviors and Insistence on Sameness/ Circumscribed Interests. This classification
merges the four ICD-10 categories into two. Preoccupations with part-objects and
stereotyped motor mannerisms formed a single Sensory/Motor factor; circumscribed
patterns of interest and adherence to routines became a single Sameness/Circumscribed
Interest factor. This 2-factor solution may have missed the distinction between sameness and
circumscribed interests reported by Lam et al. and the findings in the present study.11
Five factors have been identified for the parent-rated Repetitive Behavior Scale–Revised
(RBSR) developed by Bodfish et al.10,31,32 These factors do not precisely correspond with
ICD-10. For example, it includes an SIB factor not listed in ICD-10. As in ICD-10, the
RBSR has separate factors for stereotypic behavior, insistence on sameness and
circumscribed interests. The fifth factor included ordering and arranging and the need to
touch or tap things is similar to our Component II—but not clearly enumerated in ICD-10.
The 5-component structure identified in the current study included a larger set of behaviors
than the ADI-R. Unlike the study of the RBQ by Honey et al.,12 our study included SIB.
Component III in our analysis includes insistence on routines and SIB—which does not fit
neatly with the concept of higher and lower order repetitive behaviors,9 but has been
reported by others.35 Although SIB is multidetermined, it may be that some children resort
to SIB when routines are not followed. Consistent with the concept of lower order repetitive
behaviors, Components II (Sensory Motor) and IV (Stereotypy) in this study were associated
with nonverbal and intellectually disabled subjects. However, these 2 components emerged
as distinct in our analysis—rather than the single factor reported by others.
Taken together, repetitive behaviors exhibited by children with ASD appear to cluster in
patterns that are collapsed in some analyses and more finely delineated in others. Other
seeming discrepancies in factor analysis may be due to differences in sample characteristics,
sample size, as well as differences in the coverage of behaviors. Children with ASD often
exhibit behaviors from more than one category suggesting that repetitive behaviors are not
factor-specific. The association of motor stereotypy and sensory-motor behavior with
intellectual disability and the association of more complex ritualistic behavior with IQ ≥ 70
are replicated findings.10,11 The implications for treatment are not clear.
Consistent with the results of our previous report, this study raises questions about the
relevance of the Resistance item in the ASD population.7 In OCD, resistance may be a sign
of health. Patients who resist the urge to carry out ritualized behavior are considered less
severe on this dimension than those who do not resist.34 Given that individuals with ASD
often engage in repetitive behavior as a preferred activity, resistance is less informative.
Indeed, over 60% of the subjects in our sample had a Resistance score of 4, reflecting no
resistance. Whether the Resistance item score changes with treatment is an unanswered
empirical question. If the Resistance item is dropped, additional severity items such as
intensity of the behavior or the unusual appearance of the behavior could be developed and
tested to retain the scoring range from 0 to 20.
Our results underscore other differences in repetitive behavior in ASD compared to OCD.
Repetitive behaviors in OCD such as excessive hand washing and rituals to prevent harm
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observed in children with OCD were rarely endorsed in this sample of children with ASD.
In practice, attention to these distinctions may help with differential diagnosis. The
phenomenological dissimilarities in OCD and ASD may explain the differential response to
the selective serotonin reuptake inhibitors .35
The results of this study provide an incremental refinement on measuring repetitive behavior
in children with ASD. However, there are several limitations of this study. First, this was a
sample of convenience consisting of children selected for participation in multisite clinical
trials. The sample may not be representative of all children with ASD. Second, the symptom
checklist included a wide range of repetitive behaviors generated by an expert panel and
compulsions from the original CYBOCS. Nonetheless, we may have missed some repetitive
behaviors in children with ASD. Future research could explore whether the addition of
relevant repetitive behaviors affects the component structure. Third, we used the simple
exploratory model (PCA) in this study without assumptions about the latent structure of the
binary (present or absent) checklist items. Future studies could proceed with confirmatory
analysis to verify this component structure in youth with ASD. Fourth, the weights used to
generate component scores, which were then correlated with other measures are sample-
specific. These associations may change in magnitude in a different sample.
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Refer to Web version on PubMed Central for supplementary material.
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Table 1
Clinical Characteristics of 272 subject in 3 Research Units on Pediatric Psychopharmacology (RUPP) Autism
Network Trials
Subject variable
Gender, male, n (%) 229 (84.2)
< IQ 70a, n (%) 141(55.7)
Functional Language (on ADI-R verbal item), n (%) 198 (73.6)
Diagnosis, n (%)
    Autistic Disorder 209 (76.8)
    Asperger's Disorder 14 (5.1)
    PDD-NOS 49 (18.0)
Clinical Global Impression Severity, n (%)
    Moderate 75 (27.7)
    Marked 135(49.8)
    Severe 59 (21.8)
    Extreme 2 (.7)
Age (years), m (SD) 7.8 (2.6)
CYBOCS-ASD Total, m (SD) 14.8 (3.2)
    Time spent 2.9 (.94)
    Interference 2.4 (.91)
    Distress 2.7 (.86)
    Resistance 3.4 (.79)
    Control 3.3 (.75)
Child and Adolescent Symptom Inventory (CASI), m (SD)
    Anxiety Scale 14.7 (9.5)
    PDD scale 22.2 (7.6)
Vineland Adaptive Behavior Scales, m (SD)
    Communication 54.9 (20.9)
    Socialization 55.6 (15.9)
    Daily Living 46.1(20.4)
Aberrant Behavior Checklist, m (SD)
    Irritability 25.4 (9.3)
    Social Withdrawal 15.0 (8.9)
    Stereotypy 8.7 (5.4)
    Hyperactivity 34.1 (8.7)
    Inappropriate Speech 5.9 (3.8)
Note: ADI-R=Autism Diagnostic Interview–Revised; CASI= Child and Adolescent Symptom Inventory; CYBOCS-ASD=Children's Yale–Brown
Obsessive Compulsive Scale for children with autism spectrum disorder; PDD-NOS=pervasive developmental disorder not otherwise specified.
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a
IQ was missing for 19 subjects due to poor cooperation with testing
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Table 4
Correlations Between Principal Component Scores and Scores on Clinical Measures
I Hoarding/Ritualistic Behavior II Sensory
and
Arranging
III Sameness/SIB IV Stereotypy V Preoccupation
Age .03 .05 –.02 –.12 .23
CYBOCS-ASD Total Severitya .28* .27* .04 .09 –.07
    Time spent
.23* .25* –.02 .13 –.01
    Interference .18
.26* .02 .10 –.05
    Distress
.31* .16 .02 .06 –.15
    Resistance .10 .11 .05 –.05 .02
    Control .18 .10 .06 .03 .02
CASI
    Anxiety Scale
.30* .06 –.05 –.06 .02
    PDD scale .03
.33* .01 .18 –.01
Vineland Adaptive Behavior
Scaleb
    Communication .09
–.26* .03 –.31* –.06
    Socialization –.01
–.21* –.07 –.15 –.11
    Daily Living .02
–.21* –.01 –.17 –.10
Aberrant Behavior Checklist
    Irritability
.21* .14 .07 .20* –.02
    Social Withdrawal .08
.21* .01 .14 –.04
    Stereotypy –.05
.28* –.16 .24* –.01
    Hyperactivity .07 .07 –.06 .04 –.07
    Inappropriate Speech .17 .13 –.04 –.13 –.02
Note: CASI= Child and Adolescent Symptom Inventory; CYBOCS-ASD= Children's Yale–Brown Obsessive Compulsive Scale for children with
autism spectrum disorder; PDD = pervasive developmental disorder; SIB = self-injurious behavior.
aSpearman, all others Pearson
*
p<.003
b
Higher Vineland scores reflect better adaptive functioning, hence the negative correlations
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Table 5
Item Mean, SD, and Frequency Distribution of Children's Yale–Brown Obsessive Compulsive Scale for
Children With Autism Spectrum Disorder (CYBOCS-ASD) Severity Dimensions
Time spent Interference Distress Resistance Control
m (SD) 2.86 (.94) 2.43 (.91) 2.73 (.86) 3.45 (.79) 3.32 (.75)
Frequency Distribution, n (%)
0 (none) 2 (.7) 7 (2.6) 6 (2.2) 2 (.7) 2 (.7)
1 (mild) 24 (8.8) 33 (12.1) 18 (6.6) 3 (1.1) 3 (1.1)
2 (moderate) 58 (21.3) 92 (33.8) 57 (21.0) 30 (11.0) 26 (9.6)
3 (severe) 115 (42.3) 115 (42.3) 154 (56.6) 73 (26.8) 116 (42.6)
4 (extreme) 73 (26.8) 25 (9.2) 37 (13.6) 164 (60.3) 125 (46.0)
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